loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X

Technical details about Sarpogrelate, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: 125926-17-2, Sarpogrelate [inn], Sarpogrelate (inn), 4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic acid, 19p708e787, Unii-19p708e787
Molecular Formula
C24H31NO6
Molecular Weight
429.5  g/mol
InChI Key
FFYNAVGJSYHHFO-UHFFFAOYSA-N
FDA UNII
19P708E787

Sarpogrelate has been investigated for the treatment of Diabetes Mellitus, Diabetic Nephropathy, Coronary Artery Disease, and Renal Insufficiency, Chronic.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic acid
2.1.2 InChI
InChI=1S/C24H31NO6/c1-25(2)16-21(31-24(28)14-13-23(26)27)17-30-22-10-5-4-8-19(22)12-11-18-7-6-9-20(15-18)29-3/h4-10,15,21H,11-14,16-17H2,1-3H3,(H,26,27)
2.1.3 InChI Key
FFYNAVGJSYHHFO-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN(C)CC(COC1=CC=CC=C1CCC2=CC(=CC=C2)OC)OC(=O)CCC(=O)O
2.2 Other Identifiers
2.2.1 UNII
19P708E787
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-(dimethylamino)-1-((2-(3-methoxyphenyl)phenoxy)methyl)ethyl Hydrogensuccinate Hydrochloride

2. Mci 9042

3. Mci-9042

4. Mono-(2-(dimethylamino)-1-((2-(2-(3-methoxyphenyl)ethyl)phenoxy)methyl)ethyl)succinate Hydrochloride

2.3.2 Depositor-Supplied Synonyms

1. 125926-17-2

2. Sarpogrelate [inn]

3. Sarpogrelate (inn)

4. 4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic Acid

5. 19p708e787

6. Unii-19p708e787

7. Ncgc00167489-01

8. Ncgc00167489-03

9. Schembl49197

10. Gtpl210

11. Chembl52939

12. Sarpogrelate [who-dd]

13. Dtxsid7048328

14. Chebi:135697

15. Bcp08179

16. Bdbm50093789

17. Stk631325

18. Akos005563803

19. Db12163

20. Ncgc00167489-02

21. 4-{[1-(dimethylamino)-3-{2-[2-(3-methoxyphenyl)ethyl]phenoxy}propan-2-yl]oxy}-4-oxobutanoic Acid

22. Hy-10563

23. Cs-0002654

24. Ft-0712621

25. Ls-187,118

26. D08508

27. Q44931

28. 159s512

29. L000858

30. Sr-01000883998

31. J-513134

32. Sr-01000883998-1

33. (+-)-2-(dimethylamino)-1-((o-(m-methoxyphenethyl)phenoxy)methyl)ethyl Hydrogen Succinate

34. (- )-2-(dimethylamino)-1-((o-(m-methoxyphenethyl)phenoxy)methyl)ethyl Hydrogen Succinate.

35. 4-(1-(dimethylamino)-3-(2-(3-methoxyphenethyl)phenoxy)propan-2-yloxy)-4-oxobutanoic Acid

36. 4-((1-(dimethylamino)-3-(2-(3-methoxyphenethyl)phenoxy)propan-2-yl)oxy)-4-oxobutanoic Acid

37. 4-(1-(2-(3-methoxyphenethyl)phenoxy)-3-(dimethylamino)propan-2-yloxy)-4-oxobutanoic Acid Sarpogrelate

38. 4-[1-dimethylamino-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic Acid

39. Butanedioic Acid, Mono(2-(dimethylamino)-1-((2-(2-(3-methoxyphenyl)ethyl)phenoxy)methyl)ethyl) Ester

40. Butanedioic Acid,1-[2-(dimethylamino)-1-[[2-[2-(3-methoxyphenyl)ethyl]phenoxy]methyl]ethyl]ester

41. Succinic Acid Mono-(2-dimethylamino-1-{2-[2-(3-methoxy-phenyl)-ethyl]-phenoxymethyl}-ethyl) Ester; Hydrochloride

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 429.5 g/mol
Molecular Formula C24H31NO6
XLogP31.2
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count14
Exact Mass429.21513771 g/mol
Monoisotopic Mass429.21513771 g/mol
Topological Polar Surface Area85.3 Ų
Heavy Atom Count31
Formal Charge0
Complexity540
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Fibrinolytic Agents

Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)


Serotonin Antagonists

Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)


Platelet Aggregation Inhibitors

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)


Post Enquiry
POST ENQUIRY